Search Results - "Skaletskaya, Anna"

Refine Results
  1. 1
  2. 2
  3. 3

    A Cytomegalovirus-Encoded Inhibitor of Apoptosis That Suppresses Caspase-8 Activation by Skaletskaya, Anna, Bartle, Laura M., Chittenden, Thomas, McCormick, A. Louise, Mocarski, Edward S., Goldmacher, Victor S.

    “…We have identified a human cytomegalovirus cell-death suppressor, denoted vICA, encoded by the viral UL36 gene. vICA inhibits Fas-mediated apoptosis by binding…”
    Get full text
    Journal Article
  4. 4
  5. 5

    murine cytomegalovirus cell death suppressor m38.5 binds Bax and blocks Bax-mediated mitochondrial outer membrane permeabilization by Arnoult, Damien, Skaletskaya, Anna, Estaquier, Jérôme, Dufour, Cecilie, Goldmacher, Victor S

    Published in Apoptosis (London) (01-09-2008)
    “…Apoptosis is increasingly implicated as an early line of defense against viral infections. Viruses have devised numerous strategies to delay apoptosis of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Abstract 2186: Peptide-cleavable maytansinoid (ADCs) induce high bystander killing leading to improved anti-tumor activity in vivo by Widdison, Wayne C., Costoplus, Juliet A., Ponte, Jose F., Lanieri, Leanne, Setiady, Yulius, Dong, Ling, Skaletskaya, Anna, Wu, Rui, Qiu, Qifeng, Kovtun, Yelena, Chari, Ravi V.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Antibodies targeting surface antigens on cancer cells typically have progressively lower access to tumor cells that are further removed from blood…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Abstract 2700: ORM-6151: A first-in-class CD33-antibody enabled GSPT1 degrader for AML by Palacino, James, Lee, Pedro, Jeong, Hangyeol, Kim, Yeonjoon, Song, Yoojin, Permpoon, Uttapol, Wong, Wesley, Bai, Chen, Fishkin, Nathan, Takouri, Khuloud, Yu, Eunjun, Yi, Yong, Skaletskaya, Anna, Kim, Min-Soo, Kim, Da-Yeong, Choi, Dong-Ki, Park, Peter U.

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Targeted protein degraders (TPDs) have expanded the breadth of therapeutic options through both their catalytic mechanism of action and ability to…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Abstract 4513: IMGN289, an EGFR-targeting antibody-drug conjugate, is effective against tumor cells that are resistant to EGFR tyrosine kinase inhibitors by Setiady, Yulius Y., Dong, Ling, Skaletskaya, Anna, Pinkas, Jan, Lutz, Robert J., Lambert, John M., Chittenden, Thomas

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract EGFR is one of the oncogenic drivers in non-small-cell lung adenocarcinoma (NSCLC AC). EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib,…”
    Get full text
    Journal Article
  20. 20